Osteoporosis in patients with primary biliary cirrhosis
Authors:
- 1 October 2010
- journal article
- review article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 22 (12) , 1397-401
Abstract
Metabolic bone disease has been recognized as an important complication of chronic liver disease particularly in cholestatic disorders [primary biliary cirrhosis (PBC) and primary sclerosing cholangitis] and after liver transplantation. It includes osteoporosis and more rarely osteomalacia, which is more frequent in severe malabsorption and advanced liver disease. The pathogenesis of this disorder is complex and is likely to be multifactorial. Regardless of the etiology of osteoporosis in PBC patients, they have an increased risk of spontaneous or low-trauma fracturing leading to significant patient morbidity, deterioration of quality of life, and even patient mortality. The development of bone densitometry has allowed assessment of bone mass and then contributed in estimating the fracture risk. The gold standard of bone mineral density measurement is currently the dual- energy X-ray absorptiometry. Recommendations formulated by the World Health Organization have reported the diagnostic ranges of osteoporosis based on the t-score: patient with osteoporosis has a t-score less than -2.5 SD, osteopenia has a t-score between -1.0 and -2.5 SD and a normal individual has a t-score more than -1.0 SD. The risk of fracture shows a correlation with bone mineral density but no fracture threshold was determined and the best site of characterizing the hip fracture risk is the measure of the bone mineral density of the proximal femur. The treatment of osteoporosis in patients with PBC is largely based on trials of patients with postmenopausal osteoporosis as there are a few and smaller studies of osteoporotic patients with PBC. Bisphosphonates seem to be effective in biliary disease and are more tolerated.Keywords
This publication has 49 references indexed in Scilit:
- OsteoporosisThe Lancet, 2006
- Hyperbilirubinemia Is Not a Major Contributing Factor to Altered Bone Mineral Density in Patients With Chronic Liver DiseaseJournal of Clinical Densitometry, 2006
- The RANKL/OPG system and bone mineral density in patients with chronic liver diseaseJournal of Hepatology, 2005
- Insulin-like growth factor I gene microsatellite repeat, collagen type I??1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2004
- AGA technical review on osteoporosis in hepatic disordersGastroenterology, 2003
- Osteoclast differentiation and activationNature, 2003
- High serum osteoprotegerin and low RANKL in primary biliary cirrhosisJournal of Hepatology, 2003
- Hepatic OsteodystrophyHepatology, 2001
- Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosisEuropean Journal of Endocrinology, 1995
- Serum Vitamin D Metabolites Are not Responsible for Low Turnover Osteoporosis in Chronic Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1989